Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084849 · ClinicalTrials.gov registry record
ADPKD Cohort Study
A clinical trial of Autosomal Dominant Polycystic Kidney Disease, sponsored by Emory University.
- Completed
- Registry status
- 624
- Enrollment target
- 1
- Study location
NCT02084849 is a study of Autosomal Dominant Polycystic Kidney Disease that has completed, run by Emory University. The registered enrollment target is 624 participants, above the 92-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (578% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02084849, a study of Autosomal Dominant Polycystic Kidney Disease, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 624 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if radiology tests of the kidneys as opposed to glomerular filtration (GFR) tests (GFR test - a lab test that measures kidney function) follow progression of polycystic kidney disease (PKD) the best. PKD patients at risk for progression to renal failure (dialysis or transplantation) have been identified and include those who have been diagnosed with high blood pressure early, the presence of the PKD1 gene (the inherited abnormality responsible for the majority of PKD), men as opposed to women, those with episodes of visible blood or increased protein in their urine, and women who have experience more than three pregnancies. Individuals who are diagnosed with PKD in the first year of life or in utero (before birth) are also at high risk for progression to renal failure. This study will also facilitate understanding of human diseases at the cellular and molecular level. We will be identifying genetic factors that may influence the severity of polycystic kidney disease (PKD). You are being asked to provide a sample of blood for the purpose of DNA or other biochemical analyses.
Conditions Studied
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 1998-06 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084849
The ClinicalTrials.gov registry entry for NCT02084849 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 624 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 92-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (578% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autosomal Dominant Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02084849 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02084849 about?
NCT02084849 is a clinical study titled "ADPKD Cohort Study". The purpose of this study is to find out if radiology tests of the kidneys as opposed to glomerular filtration (GFR) tests (GFR test - a lab test that measures kidney function) follow progression of polycystic kidney disease (PKD) the best. PKD patients at risk for progression to renal failure (dial...
What is the current status of trial NCT02084849?
This trial is currently completed. The enrollment target is 624 participants. The study started on 1998-06. Estimated completion is 2015-05.
What conditions does trial NCT02084849 study?
This clinical trial studies the following conditions: Autosomal Dominant Polycystic Kidney Disease.
Who is sponsoring clinical trial NCT02084849?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02084849 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autosomal Dominant Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING
-
NOX4 and Related Biomarkers in ADPKD
RECRUITING
-
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING · Phase 2
-
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RECRUITING · Phase 1
-
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
ACTIVE NOT RECRUITING
-
Intrarenal Microvasculature in ADPKD
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.